The kinase mammalian target of rapamycin (mTOR) integrates signals triggered by energy,
stress, oxygen levels, and growth factors. It regulates ribosome biogenesis, mRNA …

Mammalian target of rapamycin (mTOR) is a serine–threonine protein kinase that regulates
several intracellular processes in response to extracellular signals, nutrient availability …

Target of rapamycin (TOR) was first identified in yeast as a target molecule of rapamycin, an
anti-fugal and immunosuppressant macrolide compound. In mammals, its orthologue is …

The mammalian target of rapamycin (mTOR) and its associated cell signaling pathways
have garnered significant attention for their roles in cell biology and oncology. Interestingly …

Neurodegenerative disorders affect a significant portion of the world's population leading to
either disability or death for almost 30 million individuals worldwide. One novel therapeutic …

Mammalian/mechanistic target of rapamycin (mTOR) is a serine-threonine kinase that
controls several important aspects of mammalian cell function. mTOR activity is modulated …

The mammalian target of rapamycin (mTOR) pathway is an essential cellular signaling
pathway involved in a number of important physiological functions, including cell growth …

Neurodegenerative disorders affect more than 30 million individuals throughout the world
and lead to significant disability as well as death. These statistics will increase almost …

The mechanistic target of rapamycin protein complex, mTORC1, has received attention in
recent years for its role in aging and neurodegenerative diseases, such as Alzheimer's …

TOR (target of rapamycin) and its mammalian ortholog mTOR have been discovered in an
effort to understand the mechanisms of action of the immunosuppressant drug rapamycin …